





Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sep 1, 2022
The Source Fall 2022
Magazine of the plasma protein therapeutics industry - Fall 2022
All
The Source Magazine

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd8639e6dc520969c141_The%20Source_Fall2022.pdf
Sep 1, 2022
The Source Fall 2022
Magazine of the plasma protein therapeutics industry - Fall 2022
All
The Source Magazine

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd8639e6dc520969c141_The%20Source_Fall2022.pdf
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
All
PPTA statements
Jun 27, 2022
Monkeypox Virus and Plasma Protein Therapies
All
PPTA statements
Apr 12, 2022
Letter to the New York State Department of Health Commissioner: New York’s Clinical Laboratory Regulations
The Plasma Protein Therapeutics Association (PPTA) is writing to request that you please consider expeditiously granting a reasonable and necessary regulatory reform for the SourcePlasma sector pertaining to two of New York’s clinical laboratory regulations.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f64c2490bcf9502656fc_Letter_to_NYDOH_Commissioner.pdf
Apr 12, 2022
Letter to the New York State Department of Health Commissioner: New York’s Clinical Laboratory Regulations
The Plasma Protein Therapeutics Association (PPTA) is writing to request that you please consider expeditiously granting a reasonable and necessary regulatory reform for the SourcePlasma sector pertaining to two of New York’s clinical laboratory regulations.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f64c2490bcf9502656fc_Letter_to_NYDOH_Commissioner.pdf
No results found